Abstract
Cerebral cavernous malformations (CCMs) are common neurovascular lesions caused by loss-of-function mutations in 1 of 3 genes, including KRIT1 (CCM1), CCM2, and PDCD10 (CCM3), and generally regarded as an endothelial cell-autonomous disease. Here we reported that proliferative astrocytes played a critical role in CCM pathogenesis by serving as a major source of VEGF during CCM lesion formation. An increase in astrocyte VEGF synthesis is driven by endothelial nitric oxide (NO) generated as a consequence of KLF2- and KLF4-dependent elevation of eNOS in CCM endothelium. The increased brain endothelial production of NO stabilized HIF-1α in astrocytes, resulting in increased VEGF production and expression of a "hypoxic" program under normoxic conditions. We showed that the upregulation of cyclooxygenase-2 (COX-2), a direct HIF-1α target gene and a known component of the hypoxic program, contributed to the development of CCM lesions because the administration of a COX-2 inhibitor significantly prevented the progression of CCM lesions. Thus, non-cell-autonomous crosstalk between CCM endothelium and astrocytes propels vascular lesion development, and components of the hypoxic program represent potential therapeutic targets for CCMs.
Keywords:
Angiogenesis; Cardiovascular disease; Cell Biology; Hypoxia; Nitric oxide.
Publication types
-
Research Support, N.I.H., Extramural
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Animals
-
Apoptosis Regulatory Proteins / deficiency
-
Apoptosis Regulatory Proteins / genetics
-
Astrocytes / pathology
-
Astrocytes / physiology*
-
Cyclooxygenase 2 / genetics
-
Cyclooxygenase 2 / metabolism
-
Disease Models, Animal
-
Disease Progression
-
Endothelial Cells / metabolism
-
Hemangioma, Cavernous, Central Nervous System / etiology
-
Hemangioma, Cavernous, Central Nervous System / pathology
-
Hemangioma, Cavernous, Central Nervous System / physiopathology*
-
Human Umbilical Vein Endothelial Cells
-
Humans
-
Hypoxia-Inducible Factor 1, alpha Subunit / metabolism
-
Kruppel-Like Factor 4
-
Kruppel-Like Transcription Factors / genetics
-
Kruppel-Like Transcription Factors / metabolism
-
Mice
-
Mice, Knockout
-
Models, Neurological
-
Mutation
-
Nitric Oxide / biosynthesis
-
Nitric Oxide Synthase Type III / genetics
-
Nitric Oxide Synthase Type III / metabolism
-
RNA, Messenger / genetics
-
RNA, Messenger / metabolism
-
Vascular Endothelial Growth Factor A / biosynthesis
Substances
-
Apoptosis Regulatory Proteins
-
Hif1a protein, mouse
-
Hypoxia-Inducible Factor 1, alpha Subunit
-
KLF2 protein, human
-
KLF4 protein, human
-
Klf4 protein, mouse
-
Kruppel-Like Factor 4
-
Kruppel-Like Transcription Factors
-
PDCD10 protein, mouse
-
RNA, Messenger
-
VEGFA protein, human
-
Vascular Endothelial Growth Factor A
-
vascular endothelial growth factor A, mouse
-
Nitric Oxide
-
Nitric Oxide Synthase Type III
-
Nos3 protein, mouse
-
Ptgs2 protein, mouse
-
Cyclooxygenase 2